Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) shares were down 2.3% on Friday . The stock traded as low as $0.38 and last traded at $0.39. Approximately 27,512 shares traded hands during trading, a decline of 77% from the average daily volume of 119,612 shares. The stock had previously closed at $0.40.
Shuttle Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.37 and a current ratio of 5.37. The business’s 50 day simple moving average is $0.41 and its 200-day simple moving average is $0.45.
Shuttle Pharmaceuticals (NASDAQ:SHPH – Get Free Report) last issued its quarterly earnings results on Thursday, March 21st. The company reported ($0.10) earnings per share for the quarter.
Shuttle Pharmaceuticals Company Profile
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers.
Read More
- Five stocks we like better than Shuttle Pharmaceuticals
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MarketBeat Week in Review – 4/22 – 4/26
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Stocks Leading the U.S. Agriculture Comeback
- Insider Trades May Not Tell You What You Think
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
